We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging... AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547. Show more
- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.8093 | -16.4481818182 | 11 | 11 | 8.55 | 1963 | 10.12926843 | CS |
4 | -4.3593 | -32.1719557196 | 13.55 | 14.12 | 8.55 | 2686 | 11.02543219 | CS |
12 | -2.4893 | -21.3125 | 11.68 | 19.93 | 8.55 | 5669 | 13.10222936 | CS |
26 | -2.4893 | -21.3125 | 11.68 | 19.93 | 8.55 | 5669 | 13.10222936 | CS |
52 | -2.4893 | -21.3125 | 11.68 | 19.93 | 8.55 | 5669 | 13.10222936 | CS |
156 | -2.4893 | -21.3125 | 11.68 | 19.93 | 8.55 | 5669 | 13.10222936 | CS |
260 | -2.4893 | -21.3125 | 11.68 | 19.93 | 8.55 | 5669 | 13.10222936 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions